CIK: 1706667 - Address: C/O Viridian Therapeutics, Inc., 221 Crescent Street, Suite 401, Waltham, MA 02453
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/5/23 20:26
1/4/23
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoses Jennifer K.NCOCFOS.dm-135.520-2-458D
2/2/22 17:20
2/1/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoses Jennifer K.NCOCFOM.d104.1102738D
1/5/22 20:25
1/5/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsMoses Jennifer K.NCOCFOS.d-1510.610-1-436D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact